α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism

Annals of Clinical and Translational Neurology

Volumn 1, Issue 7, 2014, Pages 471-478

  Rodríguez Leyva, Ildefonso ^a   Calderón Garcidueñas, Ana Laura ^b   Jiménez Capdeville, María E ^c   Rentería Palomo, Ana Arely ^a   Hernandez Rodriguez, Héctor Gerardo ^a   Valdés Rodríguez, Rodrigo ^a   Fuentes Ahumada, Cornelia ^a   Torres Álvarez, Bertha ^a   Sepúlveda Saavedra, Julio ^d   Soto Domínguez, Adolfo ^d   Santoyo, Martha E ^c   Rodriguez Moreno, José Ildefonso ^a   Castanedo Cázares, Juan Pablo ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD VERACRUZANA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; LEVODOPA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; ECCRINE GLAND; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PILOSEBACEOUS UNIT; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SKIN BIOPSY; SKIN STRUCTURE; SPINOUS CELL LAYER;

EID: 84915805753     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.78     Document Type: Article

References (39)

1. Wakabayashi K, Tanju K, Mori F. Pathology of basal ganglia in neurodegenerative diseases. Brain Nerve 2009;61:429–439.
2. Mukherjee A, Soto C. Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. Curr Opin Cell Biol 2011;23:223–230.
3. Lu Y, Prudent M, Fauvet B, et al. Phosphorylation of α-synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-synuclein in the pathogenesis of Parkinson's disease and related disorders. ACS Chem Neurosci 2011;2:667–675.
4. Uversky VN. Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci 2008;9:507–540.
5. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy body type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999;52:1269–1271.
6. Wakanayashi K, Takahashi H, Takeda S, et al. Parkinson's disease: the presence of Lewy bodies in Aurbach's and Meissner′s plexuses. Acta Neuropathol 1998;76:217–221.
7. Wakabayashi K, Takahashi H, Ohama E, Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 1990;79:581–583.
8. Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008;67:945–953.
9. Miki Y, Tomiyama M, Ueno T, et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 2010;469:357–359.
10. Jain S. Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord 2011;17:77–83.
11. Jain S, Siegle GJ, Gu C, et al. Autonomic insufficiency in pupillary and cardiovascular systems in Parkinson's disease. Parkinsonism Relat Disord 2011;17:119–122.
12. McKeith I, Mintzer J, Aarsland D. Dementia with Lewy bodies. Lancet Neurol 2004;3:19–28.
13. Yamada M. Initial cellular target in multiple system atrophy: glial cell. Rinsho Shinkeigaku 2011;51:843.
14. Irwin DJ, Cohen TJ, Grossman M, et al. Acetylated tau a novel pathological signature in Alzheimer's disease and other taupathies. Brain 2012;135(Pt 3):807–818.
15. Quinn N. Parkinsonism-recognition and differential diagnosis. BMJ 1995;310:447–452.
16. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–184.
17. De la Fuente-Fernández R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 2012;78:696–701.
18. Verrone A, Halldin C. Molecular imaging of the dopamine transporter. J Nucl Med 2010;51:1331–1334.
19. Shrivastava A. The hot cross bun sign. Radiology 2007;245:606–607.
20. Pandey S. Hummingbird sign in progressive supranuclear palsy disease. J Res Med Sci 2012;17:197–198.
21. Djaldetti R, Lev N, Melamed E. Lesions outside the CNS in Parkinson's disease. Mov Disord 2009;24:793–800.
22. Makrantonaki E, Schönknecht P, Hossini AM, et al. Skin and brain age together: the role of hormones in the ageing process. Exp Gerontol 2010;45:801–813.
23. Shishido T, Ikemura M, Obi T, et al. Alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology 2010;16:608–610.
24. Wang N, Gibbons CH, Lafo J, Freeman R. α-Synuclein in cutaneous autonomic nerves. Neurology 2013;81:1604–1610.
25. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005;65:1863–1872.
26. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263–269.
27. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670–676.
28. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) report of the NINDS-SPSP international workshop. Neurology 1996;47:1–9.
29. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119–125.
30. Kruer MC, Boddaert N. Neurodegeneration with brain iron accumulation: a diagnostic algorithm. Semin Pediatr Neurol 2012;19:67–74.
31. Litvan I, Bhatia KP, Burn DJ, et al. SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467–486.
32. Morgan JC, Mehta SH, Sethi KD. Biomarkers in Parkinson's disease. Curr Neurol Neurosci Rep 2010;10:423–430.
33. Pandya M, Kubu CS, Giroux ML. Parkinson disease: not just a movement disorder. Clevel Clin J Med 2008;75:856–864.
34. Wenning GK, Krismer F, Poewe W. New insights into atypical parkinsonism. Curr Opin Neurol 2011;24:331–338.
35. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010;119:689–702.
36. Shengli Xu, Zhou Ming, Shun Yu, et al. Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells. Biochem Biophys Res Commun 2006;342:330–335.
37. Zhou M, Xu S, Mi J, et al. Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress. Brain Res 2013;1500:19–27.
38. Cubo E, Doumbe J, Martinez-Martin P, et al. Comparison of clinical profile of Parkinson′s disease between Spanish and Cameroonian cohorts. J Neurol Sci 2013;336:122–126.
39. Dluzen DE, McDermott JL. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease. J Gend Specif Med 2000;3:36–42.